CAR T-cell therapy requires maintaining patient-derived T cells under highly controlled conditions, from bioreactors (for growing these cells) to the cold chain. The following are the main parameters that need to be monitored and maintained throughout the pipeline for successful CAR T-cell production:
|
|
Learn about how you can control these variables and some general guidelines to ensure a constant and stable environment for your CAR T-cells during growth, short term and long term storage, and shipping.